Acesso livre
Acesso livre

Hematologia Geral

Revisão | Trombocitopenia trombótica imune induzida por vacina.

16 Nov, 2021 | 12:46h

Vaccine-induced immune thrombotic thrombocytopenia – The Lancet Haematology

Conteúdos relacionados:

Vaccine induced immune thrombocytopenia and thrombosis: summary of NICE guidance.

Clinical features of vaccine-induced immune thrombocytopenia and thrombosis.

Review: Clinical characteristics and pharmacological management of COVID-19 vaccine–induced immune thrombotic thrombocytopenia with cerebral venous sinus thrombosis.

Vaccine-induced immune thrombotic thrombocytopenia: what we know and do not know.

Very rare cases of thrombosis with thrombocytopenia syndrome (TTS) after AstraZeneca vaccine: a global safety database analysis – the estimated rate of TTS after the first dose was 8.1 per million vaccinees; after the second dose, the estimated rate was 2.3 per million vaccinees. (vários artigos e fontes sobre o tema)

 

Comentário no Twitter

 

#AHA21 – [Ainda não publicado] | Um estudo pequeno e randomizado mostrou que interromper o ticagrelor apenas 2-3 dias antes da cirurgia de by-pass pode ser seguro.

15 Nov, 2021 | 13:46h

Comunicado de imprensa: Ticaglelor may be stopped Time from stopping blood thinner to bypass surgery may be shortened for select patients – American Heart Association

Comentário: RAPID CABG: No Penalty to Early Surgery for ACS After Stopping Ticagrelor – TCTMD

Estudo randomizado | Em pacientes com doença renal crônica e anemia em tratamento dialítico, a medicação oral daprodustate foi não inferior a darbepoetina alfa em aumentar os níveis de hemoglobina e também em relação aos desfechos cardiovasculares.

8 Nov, 2021 | 12:33h

Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis – New England Journal of Medicine (link para o resumo – $ para o texto completo)

Comunicado de imprensa: Oral pill as safe, efficacious as conventional treatment for anemia in patients with kidney disease – Brigham and Women’s Hospital

 

Comentário no Twitter

 

Estudo randomizado | Em pacientes com doença renal crônica e anemia que não estão sendo submetidos a diálise, a medicação oral daprodustate foi não inferior a darbepoetina alfa em aumentar os níveis de hemoglobina e também em relação aos desfechos cardiovasculares.

8 Nov, 2021 | 12:32h

Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis – New England Journal of Medicine (link para o resumo – $ para o texto completo)

Comunicado de imprensa: Oral pill as safe, efficacious as conventional treatment for anemia in patients with kidney disease – Brigham and Women’s Hospital

 

Comentário no Twitter

 

Diretriz ASH emite recomendação condicional contra o uso rotineiro de anticoagulação profilática ambulatorial em pacientes com COVID-19 depois da alta hospitalar.

4 Nov, 2021 | 12:03h

American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on post-discharge thromboprophylaxis – Blood Advances

Anticoagulantes e agentes para diabetes estão entre as causas mais frequentes de entrada nos departamentos de emergência atribuídas a danos farmacológicos.

27 Out, 2021 | 12:25h

US Emergency Department Visits Attributed to Medication Harms, 2017-2019 – JAMA (link para o resumo – $ para o texto completo)

Comentários:

Number of emergency room visits for medication harms increases with age – MedicalResearch.com

Blood thinners, diabetes meds among top causes of drug-related ER visits – UPI

Diretriz | Estratégias de transfusão de sangue no sangramento de adultos criticamente doentes.

25 Out, 2021 | 12:58h

Transfusion strategies in bleeding critically ill adults: a clinical practice guideline from the European Society of Intensive Care Medicine – Intensive Care Medicine

 

Comentário no Twitter

 

Diretriz NCCN | Doença tromboembólica venosa associada a câncer.

21 Out, 2021 | 11:25h

Cancer-Associated Venous Thromboembolic Disease, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology – Journal of the National Comprehensive Cancer Network

Conteúdos relacionados:

ASH 2021 guidelines for prevention and treatment of venous thromboembolism in patients with cancer

Review: venous and arterial thromboembolism in patients with cancer.

Systematic Review: Does testing for cancer in people with unprovoked blood clots in the legs and lungs reduce cancer- and blood clot-related death and illness?

M-A: Extended thromboprophylaxis after hospital discharge for medically ill patients with cancer – Extended thromboprophylaxis is not associated with a reduced rate of venous thromboembolic events and is associated with increased risk of hemorrhage

Systematic review: Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy

Resumo de Política da OMS | A necessidade urgente de se implementar o manejo de sangue do paciente.

20 Out, 2021 | 11:58h

The urgent need to implement patient blood management: policy brief – World Health Organization

Diretriz | Manejo de agentes anticoagulantes e antiplaquetários na cirurgia cutânea.

19 Out, 2021 | 12:46h

S3 guideline: Management of anticoagulants and antiplatelet agents in cutaneous surgery – Journal of the German Society of Dermatology

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.